HiQuin 4% Pro-Whitening Depigmenting Cream – 30g
- Weight: 30.00g
- Dimensions: 4.00cm x 4.00cm x 8.00cm
Advanced Cutaneous De-Pigmentation, Melanin Synthesis Blockade, and Intense Tone Corrections: The High-Potency Dermatological Hydroquinone Treatment for Fading Stubborn Brown Spots, Melasma, and Solar Lentigines
Reclaim an absolute, flawlessly unified, and luminous skin tone with the high-potency action of HiQuin 4% Pro-Whitening Cream (30g). Engineered to provide definitive maximum strength dermatological therapy, this specialized medical topical cream is explicitly formulated for lightening the face and body. By targeting the intracellular pathways of melanogenesis, it effectively reduces the accumulation of skin pigmentation and impedes its formation, noticeably lightening brown spots on the skin. Under clinical supervision, it systematically breaks down hyperpigmented areas, resulting in a completely clarified, smooth, and texturally balanced skin surface.
Product Highlights & Advanced Structural Benefits
Comprehensive Dermal Whitening Matrix: Expertly engineered formulation targeted at effectively lightening the face and body.
Stubborn Dark Patch Clearance: Reduces the appearance and lightens brown spots on the skin caused by photoaging or hormonal changes.
Melanocyte Activity Suppression: Operates by reducing the accumulation of skin pigmentation and impedes its further synthesis.
Maximum Strength 4% Formula: Developed for profound hyperpigmentation cases, such as resistant chloasma and post-inflammatory dark marks that do not adapt to milder concentrations.
Skin Tone Equalization: Blends hyperpigmented lesions seamlessly with your natural skin background for a smooth, uniform complexion.
Detailed Product Specification
Brand Identity: HiQuin (هاي كوين) - Jamjoom Pharmaceuticals Co.
Product Title: HiQuin 4% Pro-Whitening Cream (هاي كوين 4٪ كريم التبييض 30 جم).
Volume Weight: 30 grams clinical aluminum squeeze tube.
Active Formulation Core: High-concentration Hydroquinone at 4% w/w.
Classification Profile: High-Potency Skin Lightening Compound, Intensive Anti-Hyperpigmentation Agent, Deep Melasma and Freckle Shield.
Step-by-Step Professional Application Protocols
Preliminary Patch Testing: Always conduct a localized patch test on a small section of your skin (such as the inner wrist) before wide deployment to ensure absence of hypersensitivity.
Skin Conditioning Preparation: Cleanse the targeted area using a mild, non-medicated facial wash and pat completely dry.
Precision Application Routine: Apply a thin layer of cream exactly on the hyperpigmented dark patches twice daily (in the morning and at bedtime), avoiding any overlapping on healthy skin surfaces.
Anatomical Boundary Isolation: Formulated strictly for external topical boundaries. Keep completely isolated from the eyes, inner nostrils, and oral mucosal pathways.
Post-Application Sanitization: Thoroughly wash your hands with soap and water immediately after application to prevent unintentional depigmentation of your fingertips.
Storage Standards & Critical Material Safeties (Crucial Safeties)
Compulsory Photoprotection Regimen: A broad-spectrum medical sunscreen (SPF 50) must be applied every morning during treatment. UV exposure can completely reverse the therapeutic effect and induce intense rebound hyperpigmentation.
Absolute Contraindications: Do not use if you are pregnant, nursing, planning a pregnancy, or have a known history of allergy to hydroquinone.
Temporal Usage Limitations: Limit continuous usage to a maximum of 2 to 3 months unless instructed otherwise by your treating dermatologist to prevent exogenous ochronosis risks.
Adverse Reaction Protocol: In the event of intense skin erythema, severe burning, or swelling, immediately discontinue usage and flush the skin with cold water.
Preservation Parameters: Store the tube in a stable, cool environment between 20°C to 25°C. Keep protected from direct sunlight, thermal sources, and humidity, keeping the cap locked tight to prevent active ingredient oxidation.
Child Security Directive: Keep this highly active clinical compound securely out of the reach of infants and small children.
